Gliadel polymer implant to release carmustine: Filed a Treatment IND, with an NDA submission anticipated by year-end

Guilford Pharmaceuticals Inc. (GLFD), Baltimore Product: Gliadel polymer implant to release carmustine Indication: Malignant glioma Status: Filed a Treatment IND, with an NDA submission anticipated ...